GABRIELLA MCCARTY: Open Payments
NPI 1508896754 · WESTLAKE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$35,824 in 101 payments from 17 companies in 2025. Trend: 2023 $29,856 · 2024 $73,400 · 2025 $35,824
Speaker / faculty: $15,623Consulting: $9,858Travel & lodging: $6,072Food & beverage: $2,467Speaker / faculty: $1,805
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 25 | $9,729 |
| Intercept Pharmaceuticals, Inc. | 16 | $5,660 |
| Ardelyx, Inc. | 13 | $3,988 |
| Phathom Pharmaceuticals, Inc. | 4 | $3,028 |
| Ipsen Biopharmaceuticals, Inc | 7 | $2,757 |
| Genentech USA, Inc. | 6 | $2,675 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $2,262 |
| Madrigal Pharmaceuticals | 5 | $2,129 |
| PFIZER INC. | 4 | $1,596 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $1,538 |
Products named: OMVOH, OCALIVA, IBSRELA, VOQUEZNA, REZDIFFRA, VELSIPITY, TRULANCE, IQIRVO.
Industry payments across OH — which companies pay providers there.
